Clinical Trial Detail

NCT ID NCT01644773
Title Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

malignant glioma

Therapies

Crizotinib + Dasatinib

Age Groups: child

No variant requirements are available.